Exco InTouch's Co-Founder Tim Davis is interviewed in Bio-IT World...
Harlow, Essex (UK)-based Exco InTouch recently released the latest version of its contact management software, known as REACT, which uses cell phone text messaging to do everything from pre-screening potential clinical trial participants to sending treatment and appointment reminders to enrolled subjects.
Exco InTouch, the leading mobile messaging provider for the pharmaceutical industry, announces the introduction of ATLAS™, providing secure and cost-effective short message service (SMS) integration with pharmaceutical and healthcare systems such as EDC and CTMS. This unique, regulatory-compliant enterprise system is used to send SMS messages to any mobile phone across the globe in a wide range of languages. ATLAS is capable of processing over 50 messages per second, and can deliver to over 600 mobile phone operators in more than 200 countries, providing sponsors with unparalleled access capabilities including strong links with Verizon, Motorola and Nokia.
Exco InTouch will be exhibiting at the 44th Drug Information Association Annual Meeting from June 22nd to June 25th.
Key Details:
What: Booth Nos 1647/1648
Where: Boston Convention & Exhibition Center, Boston, MA, USA
Exco InTouch announces the availability of its new technical paper, 'Electronic Data Capture Using the WOMAC™ NRS 3.1 Index: a Pilot Study of Cellular Technology in OA'.
Exco InTouch the leading mobile messaging provider for the pharmaceutical industry, announces that it has partnered with US-headquartered MMG an international industry leader in patient enrolment for clinical trials to enhance the efficacy of patient recruitment and retention services for pharmaceutical sponsors. The integration of Exco InTouch's REACT™ short messaging service (SMS) technology will complement MMG's services, enhancing the company's ability to quickly find good quality patients through advertising, pre-screening and selection. Additionally, Exco InTouch's innovative mobile technology allows MMG to interact directly with subjects during a clinical study, which can significantly improve retention for faster and more cost-effective trials.
Exco InTouch, the leading mobile messaging provider for the pharmaceutical industry, announces that its electronic patient reported outcomes (ePRO) solutions have been selected by Synairgen, a drug discovery company focused on asthma and chronic obstructive pulmonary disease (COPD). Exco InTouch's short message service (SMS) ePRO offerings will enable Synairgen to collect patient data in its second clinical study of inhaled interferon beta (IFN-beta) for asthma treatment.
Exco InTouch, the leading mobile messaging provider for the pharmaceutical industry, has been presented with the Best IT Strategy award at the 2008 European Outsourcing Awards. The prestigious industry awards were held in Frankfurt on October 1, 2008 by Via Media Ltd, a dynamic media company specialising in printed and digital publications for a wide range of industries including pharmaceutical, biopharmaceuticals and life sciences. The international judging panel took into account a number of factors when awarding the honours including the effective deployment of the technology and its benefits to users.
Exco InTouch, the leading provider of patient communication solutions for the pharmaceutical and healthcare sectors announces that it came in second at the prestigious 2008 Good Clinical Practice Journal (GCPj) Awards in the category of Most Innovative Patient Recruitment Strategy. The awards were organised by Informa Healthcare, the leading provider of business information for the biotechnology and medical devices industries and involved a panel of judges from prominent global pharmaceutical organisations. This recognition follows Exco InTouch's recent success at the European Outsourcing Awards and was received in recognition of the company's text message-based participant communication strategy developed for MDS Pharma Services.
Exco InTouch, the provider of interactive patient communication solutions today announced the results of a successful pre-conference workshop at the Patient Recruitment and Retention conference in Amsterdam, October 13th – 15th 2008. The event, run in partnership with the patient recruitment agency MMG, focused on the use of proven methods and exploration of new technology to improve patient recruitment, retention and compliance within clinical research.
Exco InTouch, the leading mobile messaging provider for the pharmaceutical industry, announces that its text messaging technology ATLAS™ has been selected by Pfizer, one of the world's leading pharmaceutical companies to enhance the efficacy of its patient recruitment and retention in Phase I clinical trials. Exco InTouch's integrated system will enable Pfizer to quickly identify, contact and assess relevant patients and maintain patient communication throughout the life of its trials across Belgium, Singapore and the US. Traditional methods of patient recruitment such as letter-based processes can often be time-consuming, costly and sometimes ineffective. Text message-based methods are quick and non-intrusive, offering healthcare providers a simple, cost-effective and direct-to-patient system of communication.
Subject noncompliance in clinical trials ranges from 20% to 80%, depending on the therapeutic area. This is due to a number of factors, including subjects failing to follow medication regimes, missing clinical visits, and failing to comply with crucial requirements of the study. Replacing noncompliant subjects can have a significant impact on cost, recruitment, timelines, and the data quality of a clinical study. As a result, overcoming subject noncompliance is an increasingly important issue in the pharmaceutical industry.
